Unverified50% confidenceFactExact time
A drug candidate designed from scratch by Insilico Medicine using AI has entered Phase II clinical trials.
1
Sources
50%
Confidence
Medium-term (~90 days)
Relevance
9/4/2026
First Seen
Valid until: 12/3/2026
Sources
Related Entities
Related Claims
Unverified医疗AI临床落地需要通过随机对照试验验证，FDA对SaMD有专门监管框架，欧盟AI法案将医疗AI列为高风险类别68% similarUnverifiedThe 2023 Biden administration AI Executive Order requires frontier AI systems to undergo dual-use biotechnology safety testing before release.64% similarUnverifiedAI2（艾伦人工智能研究所）提出AI Scientist框架，能实现从选题到论文初稿的自主科研闭环64% similarUnverified生成式AI从实验室走向大规模应用仅用了不到两年时间62% similarUnverifiedIn the testing industry, the ability to use AI to generate scripts and the ability to deploy AI automation in real projects are two entirely different levels of capability.62% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/852603API
curl https://kongchang.com/api/v1/knowledge/claims/852603MCP
get_claim(id=852603)